Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Patent
1998-04-07
1999-06-15
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
424486, 424487, 424489, 5147723, 5147726, 514805, 514965, A61K 914, A61K 916
Patent
active
059120150
ABSTRACT:
The present invention relates to a composition for the modulated release of a biologically active agent. The composition comprises a biocompatible polymeric matrix, a biologically active agent which is dispersed within the polymeric matrix, and a metal cation component which is separately dispersed within the polymeric matrix, whereby the metal cation component modulates the release of the biologically active agent from the polymeric matrix. The present invention also relates to a method for modulating the release of a biologically active agent from a biocompatible polymeric matrix, comprising the steps of dissolving a biocompatible polymer in a solvent to form a polymer solution and also separately dispersing a metal cation component and a biologically active agent within the polymer solution. The polymer solution is then solidified to form a polymeric matrix, wherein at least a significant portion of the metal cation component is dispersed in the polymeric matrix separately from the biologically active protein, and whereby the metal cation component modulates the release of the biologically active agent from the polymeric matrix.
REFERENCES:
patent: 3523906 (1970-08-01), Vrancken et al.
patent: 3691090 (1972-09-01), Kitajima et al.
patent: 3737337 (1973-06-01), Schnoring et al.
patent: 3887699 (1975-06-01), Yolles
patent: 3891570 (1975-06-01), Fukushima et al.
patent: 3928566 (1975-12-01), Briggs et al.
patent: 4166800 (1979-09-01), Fong
patent: 4235236 (1980-11-01), Theeuwes
patent: 4237114 (1980-12-01), Cardarelli
patent: 4252791 (1981-02-01), Grossberg et al.
patent: 4389330 (1983-06-01), Tice et al.
patent: 4391797 (1983-07-01), Folkman et al.
patent: 4530840 (1985-07-01), Tice et al.
patent: 4530901 (1985-07-01), Weissmann
patent: 4542025 (1985-09-01), Tice et al.
patent: 4637905 (1987-01-01), Gardner
patent: 4655777 (1987-04-01), Dunn et al.
patent: 4675189 (1987-06-01), Kent et al.
patent: 4711782 (1987-12-01), Okada et al.
patent: 4732889 (1988-03-01), Cynshi et al.
patent: 4767628 (1988-08-01), Hutchinson
patent: 4806524 (1989-02-01), Kawaguchi et al.
patent: 4835139 (1989-05-01), Tice et al.
patent: 4853218 (1989-08-01), Yim et al.
patent: 4871538 (1989-10-01), Yim et al.
patent: 4879272 (1989-11-01), Shimoda et al.
patent: 4891225 (1990-01-01), Langer et al.
patent: 4897268 (1990-01-01), Tice et al.
patent: 4906474 (1990-03-01), Langer et al.
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 4981696 (1991-01-01), Loomis et al.
patent: 4992419 (1991-02-01), Woog et al.
patent: 5019400 (1991-05-01), Gombotz et al.
patent: 5075115 (1991-12-01), Brine
patent: 5122367 (1992-06-01), Ron et al.
patent: 5126147 (1992-06-01), Silvestri et al.
patent: 5145674 (1992-09-01), Lane et al.
patent: 5176907 (1993-01-01), Leong
patent: 5192741 (1993-03-01), Orsolini et al.
patent: 5344654 (1994-09-01), Rueger et al.
patent: 5413797 (1995-05-01), Khan et al.
patent: 5441734 (1995-08-01), Reichert et al.
patent: B14985404 (1992-04-01), Mitchell
Pratt, L., et al., "The Effect of Ionic Electrolytes on Hydrolytic Degradation of Biodegradable Polymers: Mechanical and Thermodynamic Properties and molecular Modeling," J. Polymer Science 31(7):1759-1769 (1993).
Costantino, H. R., et al., "Solid-Phase Aggregation of Proteins under Pharmaceutically Relevant Conditions," J. of Pharmaceutical Sciences, 83(12):1662-1669 (1994).
Costantino, H. R., et al., "Moisture-Induced Aggregation of Lyophilized Insulin," Pharmaceutical Research, 11(1):21-29 (1994).
Costantino, H.R., et al., "Aggregation of a Lyophilized Pharmaceutical Protein, Recombinant Human Albumin: Effect of Moisture and Stabilization by Excipients," Biotechnology, 13:493-496 (1995).
Creighton, T.E., "Physical Forces That Determine the Properties of Proteins," In Proteins, Structures and Molecular Principles, (NY: W.H. Freeman and Company), pp. 149-150.
Cunningham, B. C., et al., "Dimerization of Human Growth Hormone by Zinc," Science, 253:545-548 (Aug. 1991).
Sato, Toyomi, et al., "Porous Biodegradable Microspheres for Controlled Drug Delivery. I. Assessment of Processing Conditions and Solvent Removal Techniques," Pharmaceutical Research, 5(1):21-29 (1988).
Langer, R., "New Methods of Drug Delivery," Science, 249:1527-1533 (Sep. 1990).
Liu, W. R., et al., "Moisture-Induced Aggregation of Lyophilized Proteins in the Solid State," Biotechnology and Bioengineering, 37:177-184 (1991).
Lu, W., and park, T. G., "Protein Release from poly(lactic-co-glycolic acid) Microspheres: Protein Stability Problems," PDA J. of Pharmaceutical Science & Technology, 49(1):13-19 (Jan.-Feb. 1995).
Cohen, S., et al., "Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres," Pharmaceutical Research, 8(6):713-720 (1991).
Hora, M.S. et al., "Release of Human Serum Albumin from Poly(lactide-co-glycolide) Microspheres," Pharmaceutical Research, 7(11):1190-1194 (1990).
Hageman, M.J., et al., "Preformulation Studies Oriented Toward Sustained Delivery of Recombinant Somatotropins," J. Agric. Food Chem., 40:348-355 (1992).
Cleland, J. L., et al., "Characterization of Recombinant Human Growth Hormone-PLGA Formulations in Animals," Proceed, Intern. Symp. Control. Rel. Bioact. Mater., 22:143-144 (1995).
Cleland, J. L., et al., "One Month Continuous Release Recombinant Human Growth Hormone-PLGA Formulations," Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 22:149-150 (1995).
Mullerad, J., et al., "Delivery of IL-1 Microspheres to Tumor Macrophages," Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 22:512-513 (1995).
Cleland, J. L., et al., "In Vitro Release of Bioactive Recombinant Human Interferon-.gamma. From PLGA Microspheres," Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 22:518-519 (1995).
Park, T. G., et al., "Importance of In Vitro Experimental Conditions on Protein Release Kinetics, Stability and Polymer Degradation in Protein Encapsulated Poly(D,:-Lactic Acid-Co-Glycolic Acid) Microspheres," J. of Controlled Release, 33:211-222 (1995)
Nagata, S., et al., "Synthesis in E. Coli of a Polypeptide with Human Leukocyte Interferon Activity," Nature, 284:316-320 (Mar. 1980).
Rubinstein, M., "The Structure of Human Interferons," Biochimica et Biophysica Acta., 695:5-16 (1982).
Sah, H., et al., "The Influence of Biodegradable Microcapsule Formulations on the Controlled Release of a Protein," J. of Controlled Release 30:201-211 (1994).
Bernstein Howard
Khan M. Amin
Tracy Mark A.
Zhang Yan
Alkermes Controlled Therapeutics Inc.
Page Thurman K.
Spear James M.
LandOfFree
Modulated release from biocompatible polymers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulated release from biocompatible polymers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulated release from biocompatible polymers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-401111